AR059902A2 - Complejo de factor viii/vwf o factor viii:c - Google Patents

Complejo de factor viii/vwf o factor viii:c

Info

Publication number
AR059902A2
AR059902A2 ARP070101059A ARP070101059A AR059902A2 AR 059902 A2 AR059902 A2 AR 059902A2 AR P070101059 A ARP070101059 A AR P070101059A AR P070101059 A ARP070101059 A AR P070101059A AR 059902 A2 AR059902 A2 AR 059902A2
Authority
AR
Argentina
Prior art keywords
factor
viii
vwf
factor viii
complex
Prior art date
Application number
ARP070101059A
Other languages
English (en)
Inventor
Arthur Mitterer
Bernhard Fischer
Oyvind L Schonberger
Kathrin Thomas-Urban
Friedrich Dorner
Jonhann Eibl
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3487946&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR059902(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Immuno Ag filed Critical Immuno Ag
Publication of AR059902A2 publication Critical patent/AR059902A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/37—Factors VIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente se refiere a un complejo de factor VIII/vWF obtenible mediante cromatografía de intercambio cationico. Reivindicacion 1: Un complejo Factor VIII/factor von Willebrand (Factor VIII/vWF) caracterizado porque contiene multímeros de alto peso molecular que tienen una actividad vWF específica de al menos 66 U/mg de proteína y una actividad específica de Factor VIII de al menos 500 U/mg de proteína.
ARP070101059A 1997-02-27 2007-03-15 Complejo de factor viii/vwf o factor viii:c AR059902A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0033897A AT406373B (de) 1997-02-27 1997-02-27 Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Publications (1)

Publication Number Publication Date
AR059902A2 true AR059902A2 (es) 2008-05-07

Family

ID=3487946

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980100835A AR010121A1 (es) 1997-02-27 1998-02-25 MÉTODO DE RECUPERACIoN DE COMPLEJO DE FACTOR VIII/FACTOR DE VON WILLEWBRAND (COMPLEJO DE FACTOR VIII/VWF) MEDIANTE CROMATOGRAFíA DE INTERCAMBIO CATIoNICO.
ARP070101059A AR059902A2 (es) 1997-02-27 2007-03-15 Complejo de factor viii/vwf o factor viii:c

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980100835A AR010121A1 (es) 1997-02-27 1998-02-25 MÉTODO DE RECUPERACIoN DE COMPLEJO DE FACTOR VIII/FACTOR DE VON WILLEWBRAND (COMPLEJO DE FACTOR VIII/VWF) MEDIANTE CROMATOGRAFíA DE INTERCAMBIO CATIoNICO.

Country Status (11)

Country Link
US (3) US6831159B1 (es)
EP (1) EP0971958B2 (es)
JP (1) JP4250771B2 (es)
AR (2) AR010121A1 (es)
AT (2) AT406373B (es)
AU (1) AU744919B2 (es)
CA (1) CA2282841C (es)
DE (1) DE59814211D1 (es)
ES (1) ES2306471T5 (es)
NO (2) NO324902B1 (es)
WO (1) WO1998038220A1 (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
EP1593388A1 (en) * 2004-05-05 2005-11-09 ZLB Behring GmbH Therapeutic plasma protein-concentrates containing von willebrand factor as high molecular weight multimers
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
ES2298096B1 (es) 2008-01-08 2009-01-01 Grifols, S.A. Procedimiento para la obtencion de un concentrado de factor von willebrand o del complejo de factor viii/factor von willebrand y utilizacionde los mismos.
PT2349314E (pt) 2008-10-21 2013-05-28 Baxter Int Formulações de vwf recombinante liofilizado
CA2771232A1 (en) * 2009-08-20 2011-02-24 Baxter International Inc. Purification of vwf for increased removal of non-lipid enveloped viruses
EP2499165B1 (en) 2009-11-13 2016-09-14 Grifols Therapeutics Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
KR101871683B1 (ko) 2010-07-30 2018-06-27 이엠디 밀리포어 코포레이션 크로마토그래피 매질 및 방법
AU2011343813B2 (en) 2010-12-15 2015-05-21 Takeda Pharmaceutical Company Limited Eluate collection using conductivity gradient
WO2012171031A1 (en) * 2011-06-10 2012-12-13 Baxter International Inc. Treatment of coagulation disease by administration of recombinant vwf
WO2013019964A1 (en) 2011-08-02 2013-02-07 Baxter International, Inc. Systems and methods to increase protein yield from recombinant manufacturing processes
US8946460B2 (en) 2012-06-15 2015-02-03 Commonwealth Scientific And Industrial Research Organisation Process for producing polyunsaturated fatty acids in an esterified form
EP2925777B1 (en) * 2012-11-30 2019-05-01 Centre for Bioseparation Technology-VIT Monolith-based pseudo-bioaffinity purification methods for factor viii and applications thereof
WO2015066769A1 (en) * 2013-11-08 2015-05-14 Csl Ltd. New method to concentrate von willebrand factor or complexes thereof
SG11201604871VA (en) 2013-12-18 2016-07-28 Commw Scient Ind Res Org Lipid comprising long chain polyunsaturated fatty acids
KR102527795B1 (ko) 2014-06-27 2023-05-02 커먼웰쓰 사이언티픽 앤 인더스트리알 리서치 오거니제이션 도코사펜타에노산을 포함하는 지질
ES2877563T3 (es) 2014-09-02 2021-11-17 Emd Millipore Corp Medios de cromotografía que comprenden conjuntos porosos discretos de nanofibrillas
WO2016093926A1 (en) 2014-12-08 2016-06-16 Emd Millipore Corporation Mixed bed ion exchange adsorber
PT3648788T (pt) 2017-07-07 2024-08-23 Takeda Pharmaceuticals Co Tratamento de hemorragia gastrointestinal em pacientes com doença de von willebrand grave por administração de fvw recombinante
CN114106145B (zh) * 2021-10-22 2023-09-01 山东泰邦生物制品有限公司 一种血源人凝血因子ⅷ/血管性血友病因子复合物生产工艺

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540573A (en) 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
GB8403473D0 (en) * 1984-02-09 1984-03-14 Special Trustees For St Thomas Purification of factor viii
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
FR2651437A1 (fr) * 1989-09-05 1991-03-08 Lille Transfusion Sanguine Procede de preparation de concentre du complexe facteur viii-facteur von willebrand de la coagulation sanguine a partir de plasma total.
NZ237244A (en) 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) * 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) * 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) * 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE4435392B4 (de) 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
AT403764B (de) 1996-03-15 1998-05-25 Immuno Ag Stabiler faktor viii/vwf-komplex
AT403765B (de) 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
CA2251558C (en) 1996-04-12 2005-11-22 Immuno Aktiengesellschaft Highly purified factor viii complex
AT405403B (de) 1997-02-27 1999-08-25 Immuno Ag Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie

Also Published As

Publication number Publication date
CA2282841A1 (en) 1998-09-03
US6953837B2 (en) 2005-10-11
NO994137D0 (no) 1999-08-26
ES2306471T3 (es) 2008-11-01
US20050239171A1 (en) 2005-10-27
WO1998038220A1 (de) 1998-09-03
ATE391728T1 (de) 2008-04-15
EP0971958A1 (de) 2000-01-19
AU6080698A (en) 1998-09-18
DE59814211D1 (de) 2008-05-21
ES2306471T5 (es) 2012-06-07
JP2001517212A (ja) 2001-10-02
JP4250771B2 (ja) 2009-04-08
EP0971958B2 (de) 2012-02-08
AU744919B2 (en) 2002-03-07
US20020058625A1 (en) 2002-05-16
NO324902B1 (no) 2007-12-27
US6831159B1 (en) 2004-12-14
AT406373B (de) 2000-04-25
NO20071357L (no) 1999-08-26
NO994137L (no) 1999-08-26
CA2282841C (en) 2008-12-02
US7648958B2 (en) 2010-01-19
AR010121A1 (es) 2000-05-17
EP0971958B1 (de) 2008-04-09
NO326257B1 (no) 2008-10-27
ATA33897A (de) 1999-09-15

Similar Documents

Publication Publication Date Title
AR059902A2 (es) Complejo de factor viii/vwf o factor viii:c
Furlan et al. Triplet structure of von Willebrand factor reflects proteolytic degradation of high molecular weight multimers.
NZ330897A (en) Human trk receptors and neurotropic factor inhibitors
DE69629209D1 (de) Getrocknete zubereitung von bluttfaktoren, enthaltend trehalose
FI945198A0 (fi) Farmaseuttiset ja muut annosmuodot
EA199800946A1 (ru) Концентрированный препарат антител
LU91448I2 (fr) "panitumumab"
MX9305729A (es) Formulas de proteinas de liberacion sostenida.
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
DK0672138T3 (da) Kimære prokoagulante proteiner
UA27763C2 (uk) Рекомбінантна молекула днк, що кодує молекулу адгезії icam-3, молекула адгезії icam-3, антитіло, здатне зв'язуватись з такою молекулою, фармацевтична композиція
NO307702B1 (no) Retinsyre-X-reseptorligander, anvendelse derav og farmasøytiske preparater
PT523395E (pt) Regioes sero-reactivas na proteina e1 e e2 de hpv 16
FI913470A0 (fi) Multimer form av receptorprotein hos humant rhinovirus.
ES2090273T3 (es) Estuche para el dosificado especifico de la angiotensina ii.
DE69127334D1 (de) Verabreichung von Mitteln
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
MX9302614A (es) Receptor de glutamato metabotropico humano y compuestos de dna relacionados.
FR2717808B1 (fr) Composition cosmétique stable à la lumière.
DE69806465D1 (de) Eine heteroethynylen-brücke enthaltende bi-aromatische verbindungen und diese enthaltende pharmazeutische und kosmetische zusammensetzungen
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
DE59208622D1 (de) Dentalwerkstoffe auf Basis von (Meth)-Acrylaten
ES2080060T3 (es) Proteinas que tienen actividad de union a interferon-gamma.
DE69122103D1 (de) Antigerinnungspeptide

Legal Events

Date Code Title Description
FB Suspension of granting procedure